Products

What will AGI do for Betamicin sulfate?

This classification denotes the sulfate form of an aminoglycoside antibiotic with the molecular structure C19H38N4O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 67W9DGG4C7 chemically known as d-streptamine, o-6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6))-2-deoxy-, but more commonly known as betamicin, which bears US NIH Compound Identifier 37569. European Medicines Agency schedules Betamicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05799MIG. The term BETAMICIN is an International Non-Proprietary Name or INN. Most nations, for tariff and trade purposes, schedule betamicin sulfate under HS 29419000 and SITC 54139. As of Q4 2014, BETAMICIN SULFATE remains US FDA's Preferred Term for this commodity. Betamicin sulfate bears US NLM identifiers UMLS ID C0953456 and NCI Concept Code C79527. SMILES: C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N)N)O.OS(=O)(=O)O.